Considering experimentation and elusive truth: informed consent made difficult.
D000163:Acquired Immunodeficiency Syndrome; D020811:Biomedical Technology; D003695:Delivery of Health Care; D004345:Drug Industry; D015507:Drugs, Investigational; D004467:Economics; D004864:Equipment and Supplies; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D005607:Fraud; D005818:Genetic Engineering; D006076:Government; D033161:Government Regulation; D006679:HIV Seropositivity; D006761:Hospitals; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D033281:Nontherapeutic Human Experimentation; D016134:Organizational Policy; D018579:Patient Selection; D004364:Pharmaceutical Preparations; D010817:Physician-Patient Relations; D012015:Reference Standards; D012106:Research; D035842:Research Subjects; D035844:Researcher-Subject Relations; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D019452:Terminally Ill; D036302:Therapeutic Human Experimentation; D035502:Trust; D014481:United States; D014486:United States Food and Drug Administration
Biomedical and Behavioral Research